Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 55

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 55
---
 a subsidiary’s return on capital, equity, or
assets; earnings measures/ratios (on a gross, net, pre-tax, or post-tax basis), including basic earnings per share, diluted earnings
per share, total earnings, operating earnings, earnings growth, earnings before interest and taxes and earnings before interest, taxes,
depreciation, and amortization; net economic profit (which is operating earnings minus a charge to capital); net income; operating income;
sales; sales growth; gross margin; direct margin; costs; share price (including but not limited to growth measures and total stockholder
return); operating profit; per period or cumulative cash flow (including but not limited to operating cash flow and free cash flow) or
cash flow return on investment (which equals net cash flow divided by total capital); inventory turns; financial return ratios; market
share; balance sheet measurements such as receivable turnover; improvement in or attainment of expense levels; improvement in or attainment
of working capital levels; debt reduction; strategic innovation; customer or employee satisfaction; the consummation of one or more acquisitions
of a certain size as measured by one or more of the financial criteria listed above; individual objectives; regulatory body approval
for commercialization of a product; implementation or completion of critical projects (including, but not limited to, milestones such
as clinical trial enrollment targets, commencement of phases of clinical trials and completion of phases of clinical trials); and any
combination of the foregoing.

Options

Under the 2020 Plan, the committee will determine the exercise price
of the options granted and may grant options to purchase shares of Common Stock in such amounts as it determines. The committee may grant
options that are intended to qualify as incentive stock options under Section 422 of the Code, or non-qualified stock options, which
are not intended to so qualify. Non-qualified stock options may be granted to eligible participants under the 2020 Plan, but incentive
stock options may only be granted to employees of the Company or its parent or subsidiaries that are corporations. The exercise price
of a stock option granted under the 2020 Plan cannot be less than the fair market value of a share of the Company’s Common Stock
on the date the option is granted. If an incentive stock option is granted to a 10% or greater stockholder, the exercise price cannot
be less than 110% of the fair market value of a share of the Company’s Common Stock on the date the option is granted. The aggregate